Actuate Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Actuate Therapeutics Inc's ROI in the second quarter of 2026?
Actuate Therapeutics Inc recorded a cumulative net loss of $-20 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -323.97%.

Within the Healthcare sector 207 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3655 to 4222.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-93.79 %	-97.92 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	1	4	8	11	-2
Return On Investment (TTM)	-323.97 %	-398.31 %	-719.2 %	-2327.91 %	-
ACTU's Overall Ranking	# 4222	# 3655	# 3779	# 3942	# 0
Seq. Investment Change TTM	16.77 %	74.95 %	198.29 %	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-20	-22	-22	-24	-25

ACTU Company Profile >> Back to ACTU Roi Comparisons >> See Annual ACTU Return On Investment

Return On Investment ACTU's Ranking
Within:	No.
Industry	# 84
Sector	# 208
Overall	# 4222

Return On Investment Statistics
High	Average	Low
-308.9 %	-443.17 %	-674.11 %
(Jun 30 2026)		(Dec 31 2025)

Financial Statements
Actuate Therapeutics Inc's II. Quarter Investments	$ 1 Millions	ACTU's Balance sheet
Actuate Therapeutics Inc's II. Quarter Income	$ -5 Millions	Quarterly ACTU's Income Statement
ACTU's Income by Division		See ACTU's Income by Division

ACTU Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	8	0	0	0	0
Y / Y Investment Growth	7041.72 %	-	-	-	-
Net Income in Millions	-22	-27	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-280.51 %	-24591.57 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACTU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACTU's Competitors
Subscribers only: Roi for Actuate Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ACTU's Customers

Other Ratios
ACTU's Roa	ACTU's Inventory Turnover Ratio	ACTU's Growth Rates	ACTU's Dividend Statistics
	ACTU's Profitability Ratios	ACTU's Asset Turnover Ratio	ACTU's Dividend Growth
ACTU's Roe	ACTU's Valuation Ratios	ACTU's Financial Strength Ratios	ACTU's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:43:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.